转移性割敏感前列腺癌中的TP53结构功能关系和APR-246治疗的影响

Tung Hoang1,2, Philip Sutera1, Triet Nguyen1,2,3

  • 1Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

The Prostate
|October 9, 2023
PubMed
概括

主导阴性TP53突变加剧了转移性割敏感前列腺癌 (mCSPC) 的结果. 治疗APR-246抵消了这些影响,显示了mCSPC患者TP53突变的治疗潜力.